In addition, serological responses to seven antigens (including TACC1, NUCB2, Tbdn-1 and granulin etc.)were restricted to cancer patients and investigation of their relevance for sero-diagnosis or prognosis is in progress. This evidence concerns the gene TACC1 and cancer.